Legislative and administrative monitoring and outreach on healthcare policy.
Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs.
Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs.
Legislative and administrative monitoring and outreach on use of artificial intelligence in healthcare
H.R. 197, Rural Telehealth Expansion Act
H.R. 198, Drug Pricing Transparency and Accountability Act
H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023
H.R. 1066, CARING for Social Determinants Act of 2023
H.R. 1613, Drug Price Transparency in Medicaid Act of 2023
H.R. 1843, Telehealth Expansion Act of 2023
H.R. 2534, To amend title XXVII of the Public Health Service Act to ensure the equitable treatment of covered entities and pharmacies participating in the 340B drug discount program, and for other purposes.
S. 127, Pharmacy Benefit Manager Transparency Act of 2023
S. 729, Audio-Only Telehealth for Emergencies Act
S. 731, TELEHEALTH HSA Act of 2023
S. 880, Coordinating Dual Eligible Recommendations Act
S. 1001, A bill to amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules.
S.113, Prescription pricing for the People Act
S.1339, Pharmacy Benefit Manager Reform Act
H.R. 3284, Providers and Payers Compete Act
H.R. 3561, Patient Act
S. 880, Coordinating Dual Eligible Recommendations Act
H.R. 4697, Protecting PAHPA Act
S.2624, Labor-HHS-Education Appropriations Act
H.R. 5378, Lower Costs, More Transparency ActPrice Transparency
H.R. 4368, Agriculture Appropriations Act
S. 2131, Agriculture Appropriations Act
H.R. 5860, Continuing Appropriations Act
H.R.5894, Labor-HHS-Education Appropriations Act
H.R. 6363, Further Continuing Appropriations Act
H.R. 8487, Improving Seniors Timely Access to Care Act
Duration: November 30, 2016
to
December 31, 2023
General Issues: Health Issues
Spending: about $870,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2016: House of Representatives, U.S. Senate
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Rob Mangas Chief of Staff (95-98) & Counsel (87-94), Senator Wendell Ford
Albert Wynn U.S. Congressman (92-08)
U.S. Congressman (1993-2008)
K. Laurie McKay n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2023
GREENBERG TRAURIG, LLP terminated an engagement in which they represented AmeriHealth Caritas on Jan. 22.
Original Filing: 301535456.xml
Lobbying Issues
Legislative and administrative monitoring and outreach on healthcare policy.
Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs.
Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs.
Legislative and administrative monitoring and outreach on use of artificial intelligence in healthcare
H.R. 197, Rural Telehealth Expansion Act
H.R. 198, Drug Pricing Transparency and Accountability Act
H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023
H.R. 1066, CARING for Social Determinants Act of 2023
H.R. 1613, Drug Price Transparency in Medicaid Act of 2023
H.R. 1843, Telehealth Expansion Act of 2023
H.R. 2534, To amend title XXVII of the Public Health Service Act to ensure the equitable treatment of covered entities and pharmacies participating in the 340B drug discount program, and for other purposes.
S. 127, Pharmacy Benefit Manager Transparency Act of 2023
S. 729, Audio-Only Telehealth for Emergencies Act
S. 731, TELEHEALTH HSA Act of 2023
S. 880, Coordinating Dual Eligible Recommendations Act
S. 1001, A bill to amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules.
S.113, Prescription pricing for the People Act
S.1339, Pharmacy Benefit Manager Reform Act
H.R. 3284, Providers and Payers Compete Act
H.R. 3561, Patient Act
S. 880, Coordinating Dual Eligible Recommendations Act
H.R. 4697, Protecting PAHPA Act
S.2624, Labor-HHS-Education Appropriations Act
H.R. 5378, Lower Costs, More Transparency ActPrice Transparency
H.R. 4368, Agriculture Appropriations Act
S. 2131, Agriculture Appropriations Act
H.R. 5860, Continuing Appropriations Act
H.R.5894, Labor-HHS-Education Appropriations Act
H.R. 6363, Further Continuing Appropriations Act
H.R. 8487, Improving Seniors Timely Access to Care Act
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2023
In Q3, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on Oct. 20, 2023.
Original Filing: 301511111.xml
Lobbying Issues
Legislative and administrative monitoring and outreach on healthcare policy.
Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs.
Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs.
H.R. 134, To amend title XVIII of the Social Security Act to remove geographic requirements and expand originating sites for telehealth services.
H.R. 197, Rural Telehealth Expansion Act
H.R. 198, Drug Pricing Transparency and Accountability Act
H.R. 207, Advanced Safe Testing at Residence Telehealth Act of 2023
H.R. 497, Freedom for Health Care Workers Act
H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023
H.R. 1066, CARING for Social Determinants Act of 2023
H.R. 1215, Healthcare Worker Retention Act
H.R. 1488, Affordable Insulin Now Act
H.R. 1587, Making Insulin Affordable for All Children Act
H.R. 1613, Drug Price Transparency in Medicaid Act of 2023
H.R. 1843, Telehealth Expansion Act of 2023
H.R. 2534, To amend title XXVII of the Public Health Service Act to ensure the equitable treatment of covered entities and pharmacies participating in the 340B drug discount program, and for other purposes.
S. 127, Pharmacy Benefit Manager Transparency Act of 2023
S. 146, Cap Insulin Prices Act
S. 710, Striking and Locked Out Workers Healthcare Protection Act
S. 729, Audio-Only Telehealth for Emergencies Act
S. 731, TELEHEALTH HSA Act of 2023
S. 880, Coordinating Dual Eligible Recommendations Act
S. 1001, A bill to amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules.
S.113, Prescription pricing for the People Act
S.1339, Pharmacy Benefit Manager Reform Act
H.R. 3284, Providers and Payers Compete Act
H.R. 3561, Patient Act
S. 880, Coordinating Dual Eligible Recommendations Act
H.R. 4697, Protecting PAHPA Act
S.2624, Labor-HHS-Education Appropriations Act
H.R. 5378, Lower Costs, More Transparency ActPrice Transparency
H.R. 4368, Agriculture Appropriations Act
S. 2131, Agriculture Appropriations Act
H.R. 5860, Continuing Appropriations Act
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2023
In Q2, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on July 20, 2023.
Original Filing: 301488140.xml
Lobbying Issues
Legislative and administrative monitoring and outreach on healthcare policy.
Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs.
Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs.
H.R. 134, To amend title XVIII of the Social Security Act to remove geographic requirements and expand originating sites for telehealth services.
H.R. 197, Rural Telehealth Expansion Act
H.R. 198, Drug Pricing Transparency and Accountability Act
H.R. 207, Advanced Safe Testing at Residence Telehealth Act of 2023
H.R. 497, Freedom for Health Care Workers Act
H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023
H.R. 1066, CARING for Social Determinants Act of 2023
H.R. 1215, Healthcare Worker Retention Act
H.R. 1488, Affordable Insulin Now Act
H.R. 1587, Making Insulin Affordable for All Children Act
H.R. 1613, Drug Price Transparency in Medicaid Act of 2023
H.R. 1843, Telehealth Expansion Act of 2023
H.R. 2534, To amend title XXVII of the Public Health Service Act to ensure the equitable treatment of covered entities and pharmacies participating in the 340B drug discount program, and for other purposes.
S. 127, Pharmacy Benefit Manager Transparency Act of 2023
S. 146, Cap Insulin Prices Act
S. 710, Striking and Locked Out Workers Healthcare Protection Act
S. 729, Audio-Only Telehealth for Emergencies Act
S. 731, TELEHEALTH HSA Act of 2023
S. 880, Coordinating Dual Eligible Recommendations Act
S. 1001, A bill to amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules.
S.113, Prescription pricing for the People Act
S.1339, Pharmacy Benefit Manager Reform Act
H.R. 3284, Providers and Payers Compete Act
H.R. 3561, Patient Act
H.R. 3746, Fiscal Responsibility Act
S. 880, Coordinating Dual Eligible Recommendations Act
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2023
In Q1, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on April 20, 2023.
Original Filing: 301462698.xml
Lobbying Issues
Legislative and administrative monitoring and outreach on healthcare policy.
Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs.
Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs.
H.R. 134, To amend title XVIII of the Social Security Act to remove geographic requirements and expand originating sites for telehealth services.
H.R. 197, Rural Telehealth Expansion Act
H.R. 198, Drug Pricing Transparency and Accountability Act
H.R. 207, Advanced Safe Testing at Residence Telehealth Act of 2023
H.R. 497, Freedom for Health Care Workers Act
H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023
H.R. 1066, CARING for Social Determinants Act of 2023
H.R. 1215, Healthcare Worker Retention Act
H.R. 1488, Affordable Insulin Now Act
H.R. 1587, Making Insulin Affordable for All Children Act
H.R. 1613, Drug Price Transparency in Medicaid Act of 2023
H.R. 1843, Telehealth Expansion Act of 2023
H.R. 2534, To amend title XXVII of the Public Health Service Act to ensure the equitable treatment of covered entities and pharmacies participating in the 340B drug discount program, and for other purposes.
S. 127, Pharmacy Benefit Manager Transparency Act of 2023
S. 146, Cap Insulin Prices Act
S. 710, Striking and Locked Out Workers Healthcare Protection Act
S. 729, Audio-Only Telehealth for Emergencies Act
S. 731, TELEHEALTH HSA Act of 2023
S. 880, Coordinating Dual Eligible Recommendations Act
S. 1001, A bill to amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2022
In Q4, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on Jan. 20, 2023.
Original Filing: 301441504.xml
Lobbying Issues
Legislative and administrative monitoring and outreach on healthcare policy.
Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs.
Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs.
S. 150, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021.
H.R. 955, Medicaid Reentry Act of 2021.
H.R. 379, Improving Social Determinants of Health Act of 2021.
H.R. 2903, CONNECT for Health Act of 2021.
S. 1512 CONNECT for Health Act of 2021.
S. 151, COVID HCBS Relief Act of 2021.
H.R. 525, COVID HCBS Relief Act of 2021.
H.R. 3203, To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
S. 1388, Prescription Pricing for the People Act of 2021.
S. 773, A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
S. 3799, PREVENT Pandemics Act.
H.R. 6963, Accelerated Approval Integrity Act of 2022.
H.R. 6996, Accelerating Access for Patients Act of 2022.
H.R, 7007, COVID Supplemental Appropriations Act, 2022.
H.R. 6833, Affordable Insulin Now Act.
S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022.
H.R. 7667, Food and Drug Amendments of 2022.
Implementation of H.R.5376, Inflation Reduction Act (Pub.L. 117-169)
H.R.2617, Consolidated Appropriations Act, 2023
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2022
In Q3, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on Oct. 19, 2022.
Original Filing: 301411158.xml
Lobbying Issues
Legislative and administrative monitoring and outreach on healthcare policy.
Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs.
Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs.
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
H.R. 2297, MIND Act.
S. 150, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021.
H.R. 955, Medicaid Reentry Act of 2021.
H.R. 379, Improving Social Determinants of Health Act of 2021.
H.R. 2903, CONNECT for Health Act of 2021.
S. 1512 CONNECT for Health Act of 2021.
S. 151, COVID HCBS Relief Act of 2021.
H.R. 525, COVID HCBS Relief Act of 2021.
H.R. 3203, To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
S. 1388, Prescription Pricing for the People Act of 2021.
S. 773, A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
H.R. 5376, Build Back Better Act.
H.R. 4521, America COMPETES Act of 2022.
S. 3799, PREVENT Pandemics Act.
H.R. 6963, Accelerated Approval Integrity Act of 2022.
H.R. 6996, Accelerating Access for Patients Act of 2022.
H.R, 7007, COVID Supplemental Appropriations Act, 2022.
H.R. 6833, Affordable Insulin Now Act.
S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022.
H.R. 7667, Food and Drug Amendments of 2022.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2022
In Q2, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on July 19, 2022.
Original Filing: 301387474.xml
Lobbying Issues
Legislative and administrative monitoring and outreach on healthcare policy.
Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs.
Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs.
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
H.R. 2297, MIND Act.
S. 150, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021.
H.R. 955, Medicaid Reentry Act of 2021.
H.R. 379, Improving Social Determinants of Health Act of 2021.
H.R. 2903, CONNECT for Health Act of 2021.
S. 1512 CONNECT for Health Act of 2021.
S. 151, COVID HCBS Relief Act of 2021.
H.R. 525, COVID HCBS Relief Act of 2021.
H.R. 3203, To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
S. 1388, Prescription Pricing for the People Act of 2021.
S. 773, A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
H.R. 5376, Build Back Better Act.
H.R. 4521, America COMPETES Act of 2022.
S. 3799, PREVENT Pandemics Act.
H.R. 6963, Accelerated Approval Integrity Act of 2022.
H.R. 6996, Accelerating Access for Patients Act of 2022.
H.R, 7007, COVID Supplemental Appropriations Act, 2022.
H.R. 6833, Affordable Insulin Now Act.
S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022.
H.R. 7667, Food and Drug Amendments of 2022.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2022
In Q1, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on April 20, 2022.
Original Filing: 301370904.xml
Lobbying Issues
Legislative and administrative monitoring and outreach on healthcare policy.
Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs.
Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs.
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
H.R. 2297, MIND Act.
S. 150, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021.
H.R. 955, Medicaid Reentry Act of 2021.
H.R. 379, Improving Social Determinants of Health Act of 2021.
H.R. 2903, CONNECT for Health Act of 2021.
S. 1512 CONNECT for Health Act of 2021.
S. 151, COVID HCBS Relief Act of 2021.
H.R. 525, COVID HCBS Relief Act of 2021.
H.R. 3203, To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
S. 1388, Prescription Pricing for the People Act of 2021.
S. 773, A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
S. 1693, Medical Supplies for Pandemics Act of 2021.
H.R. 3463, Medical Supplies for Pandemics Act of 2021.
H.R. 5376, Build Back Better Act.
H.R. 2471, Consolidated Appropriations Act, 2022 (P.L. 117-103).
H.R. 4521, America COMPETES Act of 2022.
S. 3799, PREVENT Pandemics Act.
H.R. 6963, Accelerated Approval Integrity Act of 2022.
H.R. 6996, Accelerating Access for Patients Act of 2022.
H.R, 7007, COVID Supplemental Appropriations Act, 2022.
H.R. 6833, Affordable Insulin Now Act.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2021
In Q4, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on Jan. 20, 2022.
Original Filing: 301333336.xml
Lobbying Issues
Legislative and administrative monitoring and outreach on healthcare policy.
Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs.
Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs.
Legislative and administrative monitoring and outreach on the implementation of the Affordable Care Act (ACA) (P.L. 111-148)
Legislative outreach related to executive action surrounding the HHS Rebate rule.
Legislative outreach and monitoring the implementation of H.R. 259, Medicaid Extenders Act of 2019 (P.L. 116-3).
Legislative outreach and monitoring the implementation of H.R. 1319, American Rescue Plan Act of 2021 (P.L. 117-2).
Legislative outreach and monitoring the implementation of H.R. 3684, Infrastructure Investment and Jobs Act. (P.L. 117-58).
Legislative and administrative monitoring and outreach on activity related to reconciliation and the congressional budget resolution.
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
H.R. 2297, MIND Act.
S. 439, Coronavirus Medicaid Response Act.
H.R. 1353, Coronavirus Medicaid Response Act.
S. 150, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021.
H.R. 955, Medicaid Reentry Act of 2021.
H.R. 379, Improving Social Determinants of Health Act of 2021.
H.R. 2903, CONNECT for Health Act of 2021.
S. 1512 CONNECT for Health Act of 2021.
S. 151, COVID HCBS Relief Act of 2021.
H.R. 525, COVID HCBS Relief Act of 2021.
H.R. 3203, To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
S. 1388, Prescription Pricing for the People Act of 2021.
H.R. 928, American Family Act of 2021.
S. 773, A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
S. 1693, Medical Supplies for Pandemics Act of 2021.
H.R. 3463, Medical Supplies for Pandemics Act of 2021.
H.R. 5376, Build Back Better Act.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2021
In Q3, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on Oct. 20, 2021.
Original Filing: 301313537.xml
Lobbying Issues
Legislative and administrative monitoring and outreach on healthcare policy.
Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs.
Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs.
Legislative and administrative monitoring and outreach on the implementation of the Affordable Care Act (ACA) (P.L. 111-148)
Legislative and administrative monitoring and outreach on issues regarding the health insurance tax (HIT).
Legislative outreach related to executive action surrounding the HHS Rebate rule.
S. 4775, Delivering Immediate Relief to America's Families, Schools and Small Businesses Act.
Legislative outreach and monitoring the implementation of H.R. 259, Medicaid Extenders Act of 2019 (P.L. 116-3).
Legislative outreach and monitoring the implementation of H.R. 1319, American Rescue Plan Act of 2021 (117-2).
Legislative and administrative monitoring and outreach on activity related to reconciliation and the congressional budget resolution.
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
H.R. 2297, MIND Act.
S. 439, Coronavirus Medicaid Response Act.
H.R. 1353, Coronavirus Medicaid Response Act.
S. 150, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021.
H.R. 955, Medicaid Reentry Act of 2021.
H.R. 379, Improving Social Determinants of Health Act of 2021.
H.R. 2903, CONNECT for Health Act of 2021.
S. 1512 CONNECT for Health Act of 2021.
H.R. 3684, Infrastructure Investment and Jobs Act.
H.R. 4161 To amend title XIX of the Social Security Act to expand access to home and community-based services (HCBS) under Medicaid, and for other purposes.
S. 151, COVID HCBS Relief Act of 2021.
H.R. 525, COVID HCBS Relief Act of 2021.
H.R. 3203, To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
S. 1388, Prescription Pricing for the People Act of 2021.
H.R. 928, American Family Act of 2021.
S. 773, A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
S. 1693, Medical Supplies for Pandemics Act of 2021.
H.R. 3463, Medical Supplies for Pandemics Act of 2021.
H.R. 5376, Build Back Better Act.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2021
In Q2, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on July 20, 2021.
Original Filing: 301291708.xml
Lobbying Issues
Legislative and administrative monitoring and outreach on healthcare policy.
Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs.
Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs.
Legislative and administrative monitoring and outreach on the implementation of the Affordable Care Act (ACA) (P.L. 111-148)
Legislative and administrative monitoring and outreach on issues regarding the health insurance tax (HIT).
Legislative outreach related to executive action surrounding the HHS Rebate rule.
S. 4775, Delivering Immediate Relief to America's Families, Schools and Small Businesses Act.
Legislative outreach and monitoring the implementation of H.R. 259, Medicaid Extenders Act of 2019 (P.L. 116-3).
Legislative outreach and monitoring the implementation of H.R. 1319, American Rescue Plan Act of 2021 (117-2).
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
H.R. 2297, MIND Act.
S. 439, Coronavirus Medicaid Response Act.
H.R. 1353, Coronavirus Medicaid Response Act.
S. 150, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021.
H.R. 955, Medicaid Reentry Act of 2021.
H.R. 379, Improving Social Determinants of Health Act of 2021.
H.R. 2903, CONNECT for Health Act of 2021.
S. 1512 CONNECT for Health Act of 2021.
H.R. 4161 To amend title XIX of the Social Security Act to expand access to home and community-based services (HCBS) under Medicaid, and for other purposes.
S. 151, COVID HCBS Relief Act of 2021.
H.R. 525, COVID HCBS Relief Act of 2021.
H.R. 3203, To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
S. 1388, Prescription Pricing for the People Act of 2021.
H.R. 928, American Family Act of 2021.
S. 773, A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
S. 1693, Medical Supplies for Pandemics Act of 2021.
H.R. 3463, Medical Supplies for Pandemics Act of 2021.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2021
In Q1, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on April 20, 2021.
Original Filing: 301267844.xml
Lobbying Issues
Legislative and administrative monitoring and outreach on healthcare policy.
Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs.
Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs.
Legislative and administrative monitoring and outreach on the implementation of the Affordable Care Act (ACA) (P.L. 111-148)
Legislative and administrative monitoring and outreach on issues regarding the health insurance tax (HIT).
Legislative outreach related to executive action surrounding the HHS Rebate rule.
S. 4775, Delivering Immediate Relief to America's Families, Schools and Small Businesses Act.
Legislative outreach and monitoring the implementation of H.R. 259, Medicaid Extenders Act of 2019 (P.L. 116-3).
H.R. 3, Lower Drug Costs Now Act of 2019
H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act
H.R. 1398, Health Insurance Tax Relief Act of 2019
H.R. 2447, Jobs and Premium Protection Act
S. 172, Health Insurance Tax Relief Act of 2019
S. 1895, Lower Health Care Costs Act
H.R. 6926, MIND Act
H.R. 133, Consolidated Appropriations Act, 2021 (P.L. 116-260).
H.R. 1319, American Rescue Plan Act of 2021 (117-2).
S. 439, Coronavirus Medicaid Response Act.
H.R. 1353, Coronavirus Medicaid Response Act.
S. 150, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021.
H.R. 955, Medicaid Reentry Act of 2021.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2020
In Q4, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on Jan. 19, 2021.
Original Filing: 301235050.xml
Lobbying Issues
Legislative and administrative monitoring and outreach on healthcare policy.
Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs.
Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs.
Legislative and administrative monitoring and outreach on the implementation of the Affordable Care Act (ACA) (P.L. 111-148)
Legislative and administrative monitoring and outreach on issues regarding the health insurance tax (HIT).
Legislative outreach related to executive action surrounding the HHS Rebate rule.
S. 4775, Delivering Immediate Relief to America's Families, Schools and Small Businesses Act.
Legislative outreach and monitoring the implementation of H.R. 259, Medicaid Extenders Act of 2019 (P.L. 116-3).
H.R. 3 Lower Drug Costs Now Act of 2019
H.R. 987 Strengthening Health Care and Lowering Prescription Drug Costs Act
H.R. 1398 Health Insurance Tax Relief Act of 2019
H.R. 2447 Jobs and Premium Protection Act
S. 172 Health Insurance Tax Relief Act of 2019
S. 1895 Lower Health Care Costs Act
HR 6926 MIND Act
H.R. 133, Consolidated Appropriations Act, 2021 (P.L. 116-260).
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2020
In Q3, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on Oct. 20, 2020.
Original Filing: 301223782.xml
Lobbying Issues
Legislative and administrative monitoring and outreach on healthcare policy.
Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs.
Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs.
Legislative and administrative monitoring and outreach on the implementation of the Affordable Care Act (ACA) (P.L. 111-148)
Legislative and administrative monitoring and outreach on issues regarding the health insurance tax (HIT).
Legislative outreach related to executive action surrounding the HHS Rebate rule.
Legislative outreach and monitoring regarding COVID-19 response, including the
implementation of: HR 748 CARES Act (PL 116-136); HR 6201 Families First
Coronavirus Act (PL 116-127); and HR 1425 Patient Protection and Affordable Care
Enhancement Act.
HR 6800 The HEROES Act
The HEALS Act (S. 4317 - S 4324)
S. 4775, Delivering Immediate Relief to America's Families, Schools and Small Businesses Act.
Legislative outreach and monitoring the implementation of H.R. 259, Medicaid Extenders Act of 2019 (P.L. 116-3).
H.R. 3 Lower Drug Costs Now Act of 2019
H.R. 987 Strengthening Health Care and Lowering Prescription Drug Costs Act
H.R. 1398 Health Insurance Tax Relief Act of 2019
H.R. 2447 Jobs and Premium Protection Act
S. 172 Health Insurance Tax Relief Act of 2019
S. 1895 Lower Health Care Costs Act
HR 6926 MIND Act
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2020
In Q2, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on July 17, 2020.
Original Filing: 301192384.xml
Lobbying Issues
Legislative and administrative monitoring and outreach on healthcare policy.
Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs.
Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs.
Legislative and administrative monitoring and outreach on the implementation of the Affordable Care Act (ACA) (P.L. 111-148)
Legislative and administrative monitoring and outreach on issues regarding the health insurance tax (HIT).
H.R. 3 Lower Drug Costs Now Act of 2019
H.R. 259 Medicaid Extenders Act of 2019 (P.L. 116-3).
H.R. 987 Strengthening Health Care and Lowering Prescription Drug Costs Act
H.R. 1398 Health Insurance Tax Relief Act of 2019
H.R. 2447 Jobs and Premium Protection Act
S. 172 Health Insurance Tax Relief Act of 2019
S. 1895 Lower Health Care Costs Act
HR 6201 Families First Coronavirus Act (PL 116-127)
HR 748 CARES Act (PL 116-136)
HR 6926 MIND Act
HR 1425 Patient Protection and Affordable Care Enhancement Act
HR 6800 The HEROES Act
HR 266, Paycheck Protection Program and Health Care Enhancement Act (PL 116-139)
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2020
In Q1, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on April 16, 2020.
Original Filing: 301168192.xml
Lobbying Issues
Legislative and administrative monitoring and outreach on healthcare policy.
Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs.
Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs.
Legislative and administrative monitoring and outreach on the implementation of the Affordable Care Act (ACA) (P.L. 111-148)
Monitor the implementation of SAMHSA final rule regarding the Confidentiality of substance use disorder patient records (83 FR 239).
Legislative and administrative monitoring and outreach on issues regarding the health insurance tax (HIT).
H.R. 3 Lower Drug Costs Now Act of 2019
H.R. 259 Medicaid Extenders Act of 2019 (P.L. 116-3).
H.R. 987 Strengthening Health Care and Lowering Prescription Drug Costs Act
H.R. 1398 Health Insurance Tax Relief Act of 2019
H.R. 2447 Jobs and Premium Protection Act
S. 172 Health Insurance Tax Relief Act of 2019
S. 1895 Lower Health Care Costs Act
H.Res.826 Expressing disapproval of the Trump administrations harmful actions towards Medicaid
HR 6201 Families First Coronavirus Act (PL 116-127)
HR 748 CARES Act (PL 116-136)
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2019
In Q4, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on Jan. 21, 2020.
Original Filing: 301125200.xml
Lobbying Issues
Legislative and administrative monitoring and outreach on healthcare policy.
Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs.
Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs.
Legislative and administrative monitoring and outreach on the implementation of the Affordable Care Act (ACA) (P.L. 111-148)
Monitor the implementation of SAMHSA final rule regarding the Confidentiality of substance use disorder patient records (83 FR 239).
Legislative and administrative monitoring and outreach on issues regarding the health insurance tax (HIT).
H.R. 3 Lower Drug Costs Now Act of 2019
H.R. 259 Medicaid Extenders Act of 2019 (P.L. 116-3).
H.R. 987 Strengthening Health Care and Lowering Prescription Drug Costs Act
H.R. 1343 Protecting Married Seniors from Impoverishment Act
H.R. 1398 Health Insurance Tax Relief Act of 2019
H.R. 2447 Jobs and Premium Protection Act
HR 3253 Empowering Beneficiaries, Ensuring Access, and Strengthening Accountability Act of 2019
S. 172 Health Insurance Tax Relief Act of 2019
S. 1895 Lower Health Care Costs Act
HR 1865 Further Consolidated Appropriations Act (PL 116-94)
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2019
In Q3, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on Oct. 21, 2019.
Original Filing: 301076977.xml
Lobbying Issues
Legislative and administrative monitoring and outreach on healthcare policy.
Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs.
Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs.
Legislative and administrative monitoring and outreach on the implementation of the Affordable Care Act (ACA) (P.L. 111-148)
Monitor the implementation of SAMHSA final rule regarding the Confidentiality of substance use disorder patient records (83 FR 239).
Legislative and administrative monitoring and outreach on issues regarding the health insurance tax (HIT).
H.R. 3 Lower Drug Costs Now Act of 2019
H.R. 259 Medicaid Extenders Act of 2019 (P.L. 116-3).
H.R. 987 Strengthening Health Care and Lowering Prescription Drug Costs Act
H.R. 1343 Protecting Married Seniors from Impoverishment Act
H.R. 1398 Health Insurance Tax Relief Act of 2019
H.R. 2447 Jobs and Premium Protection Act
HR 3253 Empowering Beneficiaries, Ensuring Access, and Strengthening Accountability Act of 2019
S. 80 Jobs and Premium Protection Act
S. 172 Health Insurance Tax Relief Act of 2019
S. 1895 Lower Health Care Costs Act
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2019
In Q2, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on July 18, 2019.
Original Filing: 301048405.xml
Lobbying Issues
Legislative and administrative monitoring and outreach on healthcare policy.
Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs.
Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs.
Legislative and administrative monitoring and outreach on the implementation of the Affordable Care Act (ACA) (P.L. 111-148)
Monitor the implementation of SAMHSA final rule regarding the Confidentiality of substance use disorder patient records (83 FR 239).
Legislative and administrative monitoring and outreach on issues regarding the health insurance tax (HIT).
H.R. 259 Medicaid Extenders Act of 2019 (P.L. 116-3).
H.R. 987 Strengthening Health Care and Lowering Prescription Drug Costs Act
H.R. 1226, ACE Kids Act
H.R. 1398 Health Insurance Tax Relief Act of 2019
H.R. 2447 Jobs and Premium Protection Act
HR 3253 Empowering Beneficiaries, Ensuring Access, and Strengthening Accountability Act of 2019
S. 80 Jobs and Premium Protection Act
S. 172 Health Insurance Tax Relief Act of 2019
S. 317, ACE Kids Act
S. 1895 Lower Health Care Costs Act
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2019
In Q1, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on April 17, 2019.
Original Filing: 301027989.xml
Lobbying Issues
Legislative and administrative monitoring and outreach on healthcare policy.
Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs.
Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs.
Legislative and administrative monitoring and outreach on the implementation of the Affordable Care Act (ACA) (P.L. 111-148).
Monitor the implementation of SAMHSA final rule regarding the Confidentiality of substance use disorder patient records (83 FR 239).
Monitor administrative action on CMS proposed interoperability rule (CMS-9115-P).
Legislative and administrative monitoring and outreach on issues regarding the health insurance tax (HIT).
H.R. 259 Medicaid Extenders Act of 2019 (P.L. 116-3).
H.R. 1226, ACE Kids Act.
S. 317, ACE Kids Act.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2018
In Q4, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on Jan. 21, 2019.
Original Filing: 301012428.xml
Lobbying Issues
Monitor and advocate on legislative and regulatory issues regarding healthcare.
Legislative monitoring and outreach related to the H.R. 6, SUPPORT for Patients and Communities Act (P.L. 115-271).
H.R. 6071, SERV Communities Act.
H.R. 6082, Overdose Prevention and Patient Safety Act.
Legislative monitoring and outreach related to the H.R. 6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 (P.L. 115-245).
H.R. 6733, Know the Cost Act of 2018.
H.R. 7052, No Federal Funds for Public Charge Act of 2018.
H.R. 7217, IMPROVE Act.
S. 2553, Know the Lowest Price Act of 2018.
S. 2554, Patient Right to Know Drug Prices Act.
S. 2680, Opioid Crisis Response Act of 2018.
S. 3120, HEAL Act of 2018.
S. 3702, Right Rebate Act of 2018.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2018
In Q3, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on Oct. 18, 2018.
Original Filing: 300989587.xml
Lobbying Issues
Monitor and advocate on legislative and regulatory issues regarding healthcare.
H.R. 6, SUPPORT for Patients and Communities Act.
H.R. 541, Improving Oversight and Accountability in Medicaid Non-DSH Supplemental Payments Act.
H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act.
H.R. 2038, Budgeting for Opioid Addiction Treatment Act.
H.R. 2843, Medicaid and CHIP Quality Improvement Act of 2017.
H.R. 5795, Overdose Prevention and Patient Safety Act.
H.R. 5797, Individuals in Medicaid Deserve Care that is Appropriate and Responsible in its Execution Act.
H.R. 6071, SERV Communities Act.
H.R. 6082, Overdose Prevention and Patient Safety Act.
H.R. 6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019
H.R. 6470, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019.
H.R. 6733, Know the Cost Act of 2018.
S.413, Improving Transparency and Accuracy in Medicare Part D Spending Act.
S. 523, Budgeting for Opioid Addiction Treatment Act.
S. 1079, Protecting Americans from Dangerous Opioids Act.
S. 1123, Office of National Drug Control Policy Reauthorization Act of 2017.
S. 2553, Know the Lowest Price Act of 2018.
S. 2554, Patient Right to Know Drug Prices Act.
S. 2680, Opioid Crisis Response Act of 2018.
S. 3120, HEAL Act of 2018.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2018
In Q2, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on July 19, 2018.
Original Filing: 300972488.xml
Lobbying Issues
Monitor and advocate on legislative and regulatory issues regarding healthcare.
H.R. 6, SUPPORT for Patients and Communities Act.
H.R. 541, Improving Oversight and Accountability in Medicaid Non-DSH Supplemental Payments Act.
H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act.
H.R. 2038, Budgeting for Opioid Addiction Treatment Act.
H.R. 2843, Medicaid and CHIP Quality Improvement Act of 2017.
H.R. 2851, SITSA Act.
H.R. 4392, To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
H.R. 4710, 340B PAUSE Act.
H.R. 5795, Overdose Prevention and Patient Safety Act.
H.R. 5797, Individuals in Medicaid Deserve Care that is Appropriate and Responsible in its Execution Act.
H.R. 6082, Overdose Prevention and Patient Safety Act.
S. 155, RAISE Act.
S.413, Improving Transparency and Accuracy in Medicare Part D Spending Act.
S. 523, Budgeting for Opioid Addiction Treatment Act.
S. 1079, Protecting Americans from Dangerous Opioids Act.
S. 1123, Office of National Drug Control Policy Reauthorization Act of 2017.
S. 1317, Medicaid and CHIP Quality Improvement Act of 2017.
S. 2453, Ensuring the Value of the 340B Program Act of 2018.
S. 2680, Opioid Crisis Response Act of 2018.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2018
In Q1, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on April 20, 2018.
Original Filing: 300957668.xml
Lobbying Issues
Monitor and advocate on legislative and regulatory issues regarding healthcare.
H.R. 1892, Bipartisan Budget Act of 2018 (P.L. 115-123).
H.R. 1625, Consolidated Omnibus Appropriations 2018 (P.L. 115-124).
H.R. 195, Extension of Continuing Appropriations Act, 2018 (P.L. 115-120).
H.R. 1301, Continuing Appropriations Amendments Act, 2018 (P.L. 115-124).
H.R. 601, Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (P.L. 115-56).
H.R. 1370, Further Additional Continuing Appropriations Act, 2018 (P.L. 115-96).
S.413, Improving Transparency and Accuracy in Medicare Part D Spending Act.
H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act.
H.R. 541, Improving Oversight and Accountability in Medicaid Non-DSH Supplemental Payments Act.
S. 1079, Protecting Americans from Dangerous Opioids Act.
H.R. 2038, Budgeting for Opioid Addiction Treatment Act.
S. 523, Budgeting for Opioid Addiction Treatment Act.
H.R. 2843, Medicaid and CHIP Quality Improvement Act of 2017.
S. 1317, Medicaid and CHIP Quality Improvement Act of 2017.
H.R. 4392, To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
H.R. 4710, 340B PAUSE Act.
S. 2453, Ensuring the Value of the 340B Program Act of 2018.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2017
In Q4, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on Jan. 18, 2018.
Original Filing: 300927436.xml
Lobbying Issues
Monitor and advocate on legislative and regulatory issues regarding healthcare.
Congressional and Administrative monitoring and Congressional outreach on the implementation of the Affordable Care Act, P.L. 111-148.
Congressional monitoring of the implementation of FY 2017 Consolidated Appropriations, P.L. 115-31.
Senate draft, Better Care Reconciliation Act.
Senate draft, Graham Cassidy
Outreach and monitoring related to comprehensive tax reform.
H. J. Res. 123, Making further continuing appropriations for fiscal year 2018, and for other purposes (P.L. 115-90).
H.R. 1, Tax Cuts and Jobs Act (P.L. 115-97).
H.R. 601, Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (P.L. 115-56).
H.R. 1370, Further Additional Continuing Appropriations Act, 2018 (P.L. 115-96).
H.R. 1628, American Health Care Act of 2017.
H.R. 2938, Road to Recovery Act.
H.R. 3921 HEALTHY KIDS Act.
S. 191, Patient Freedom Act of 2017.
S, 1827 KIDS Act of 2017.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2017
In Q3, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on Oct. 20, 2017.
Original Filing: 300916652.xml
Lobbying Issues
Monitor and advocate on legislative and regulatory issues regarding healthcare.
Congressional and Administrative monitoring and Congressional outreach on the implementation of the Affordable Care Act, P.L. 111-148.
Congressional monitoring of the implementation of FY 2017 Consolidated Appropriations, P.L. 115-31.
Senate Draft, Better Care Reconciliation Act.
Senate Draft, Graham Cassidy.
H.R. 1628, American Health Care Act of 2017.
H.R. 2938, Road to Recovery Act.
S. 191, Patient Freedom Act of 2017.
S, 1827, KIDS Act of 2017.
H.R. 3921, HEALTHY KIDS Act.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on July 20, 2017.
Original Filing: 300896725.xml
Lobbying Issues
Monitor and advocate on legislative and regulatory issues regarding healthcare.
Monitor the implementation of the Consolidated Appropriations Act 2017, P.L. 115-31.
Senate draft, Better Care Reconciliation Act.
H.R. 1628, American Health Care Act of 2017.
H.R. 2938, Road to Recovery Act.
S. 191, Patient Freedom Act of 2017.
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on April 20, 2017.
Original Filing: 300871794.xml
Lobbying Issues
Monitor and advocate on legislative and regulatory issues regarding healthcare.
H.R. 1628, American Health Care Act of 2017.
S. 191, Patient Freedom Act of 2017.
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, GREENBERG TRAURIG, LLP lobbied for AmeriHealth Caritas , earning $30,000. The report was filed on Jan. 23, 2017.
Original Filing: 300858531.xml
Lobbying Issues
Monitor and advocate on legislative and regulatory issues regarding healthcare.
H.R. 2646, Helping Families in Mental Health Crisis Act of 2016.
H.R. 34 21st Century Cures Act (P.L. 114-255).
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
Greenberg Traurig, LLP filed a lobbying registration on Dec. 1, 2016 to represent AmeriHealth Caritas, effective Nov. 30, 2016.
Original Filing: 300842330.xml
Issue(s) they said they’d lobby about: Monitor and advocate on legislative and regulatory issues regarding healthcare. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...